Contribution of lipid oxidation and ferroptosis to radiotherapy efficacy AN Pearson, J Carmicheal, L Jiang, YL Lei, MD Green International Journal of Molecular Sciences 22 (22), 12603, 2021 | 15 | 2021 |
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer KM Jungles, EA Holcomb, AN Pearson, KR Jungles, CR Bishop, ... Frontiers in Oncology 12, 1022542, 2022 | 7 | 2022 |
High-content CRISPR screening in tumor immunology EA Holcomb, AN Pearson, KM Jungles, A Tate, J James, L Jiang, ... Frontiers in Immunology 13, 1041451, 2022 | 6 | 2022 |
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis JJ Waninger, VT Ma, Z Chopra, AN Pearson, MD Green The Cancer Journal 29 (5), 279-284, 2023 | 1 | 2023 |
Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers K Sankar, AN Pearson, T Worlikar, MD Perricone, EA Holcomb, ... Translational Gastroenterology and Hepatology 8, 2023 | 1 | 2023 |
Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer Q Zhang, L Jiang, W Wang, AK Huber, VM Valvo, KM Jungles, ... JCI insight, 2024 | | 2024 |
Liver Metastases Potentiate Cancer Progression AN Pearson, E Holcomb, J James, KM Jungles, N Nedzesky, G Schaefer, ... The Journal of Immunology 210 (1_Supplement), 88.09-88.09, 2023 | | 2023 |
The radiosensitizing effects of monopolar spindle kinase I in syngeneic models of triple negative breast cancer and its implications on the tumor immune microenvironment KM Jungles, Z Wang, C Bishop, KR Jungles, C Wilson, M Liu, AN Pearson, ... The Journal of Immunology 210 (1_Supplement), 245.06-245.06, 2023 | | 2023 |
CRISPR-Cas9 screen identifies potential novel regulators of CD8+ T cell dysfunction EA Holcomb, L Jiang, A Tate, AN Pearson, Z Wang, KM Jungles, J James, ... The Journal of Immunology 210 (1_Supplement), 86.13-86.13, 2023 | | 2023 |
Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor … KM Jungles, Z Wang, CR Bishop, KR Jungles, C Wilson, M Liu, ... Cancer Research 83 (7_Supplement), 2823-2823, 2023 | | 2023 |